Express Scripts New Flex Formulary Will Prefer Lower-Priced Brand Alternatives
Executive Summary
Gilead’s authorized generics for Epclusa and Harvoni will be first alternatives to benefit from preferred coverage on the pharmacy benefit manager's National Preferred Flex Formulary.
You may also be interested in...
CVS ‘Guaranteed Net Cost’ Program Is Alternative To High Price/High Rebate Model
Program likely to generate fewer rebates so it remains to be seen whether payers will embrace the new model in a big way.
Gilead Lowering HCV Drug List Prices With Authorized Generics
Approach has been endorsed by Express Scripts as more workable solution than trying to cut list prices for drugs already on the market.
Express Scripts Rewards Low List-Priced Brands In 2019 Formulary, Retains Focus On Rebates
Mylan’s Symfi and Merck’s Zepatier gain preferred status on PBM's national preferred formulary for 2019. But more drugs are excluded from coverage – 242, up from 196 in 2018.